See the difference! Customize Seeking Alpha:
Sign in or join
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
News, Data, Transcripts
Keryx Biopharmaceuticals Inc. (KERX)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: KERX
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
Healthcare Conference Updates: Cytori, Auxilium, Keryx, Cell Therapeutics
Mike Havrilla
•
Jan 17
•
5 Comments
Keryx Biopharma: A Well-Capitalized Comeback Story with Multiple Catalysts
Mike Havrilla
•
Jan 10
•
2 Comments
Lihir Gold: A Stellar Options Trade
Marco Hickey
•
Dec 03
•
Comment!
13 Biotechs to Watch for at Hematology Conference
Michael Becker
•
Nov 30
•
Comment!
Still Believe in Antigenics
VFC's Stock House
•
Nov 24
•
8 Comments
Keryx Biopharmaceuticals' Next Price Movers Will Be Trial News
VFC's Stock House
•
Oct 27
•
4 Comments
More articles on KERX »
Latest Transcript
Keryx Biopharmaceuticals, Inc. Q2 2008 Earnings Call Transcript
Mon August 11, 2008
More transcripts on KERX »
Instablogs
Healthcare Stock Watch: My Short List of Booming (and Busting) Companies
Wed January 20, 2010
•
Marc Lichtenfeld
•
1 Comment
Wednesday's Hot Stocks on Heavy Volume & A Potential Golden Option Trade
Thu December 3, 2009
•
Marco Hickey
•
Comment!
Biotech Baker’s Dozen to Watch at Hematology Meeting
Sun November 29, 2009
•
Michael Becker
•
Comment!
Write a post on KERX
|
More Instablogs on KERX »
Sentiment
What advice would you give to
KERX?
123 characters left
What's your view of KERX?
Make sure you include KERX
140 characters left
|
Settings
Mike Havrilla
: $
KERX
// Keryx Biopharma clarifies upcoming Phase 3 colon cancer study for perifosine at BioMedReports.com //
http://bit.ly/9OuGa4
4 days ago
Mike Havrilla
: $
KERX
$
AEZS
/ Keryx, Aeterna present promising data for perifosine in late-stage colon cancer patients /
http://bit.ly/a2DQF0
Wed, Jan 27, 2010
Mike Havrilla
: $
KERX
$
AEZS
/ Keryx Biopharma Presents Updated P2 Data for Perifosine at GI-ASCO /
http://bit.ly/5HHui1
/
Sun, Jan 24, 2010
Mike Havrilla
: $
CUR
$
ISPH
$
KERX
/ Neuralstem, Inspire, Keryx FDA Calendar / clinical trial updates at
http://biomedreports.com
Thu, Jan 21, 2010
More StockTalks on KERX »